PROVEN

SHAREHOLDER

ACQUISITION

Learn About Our

Services
info-graphic-2

We

Create

Awareness.

We Are

Circadian Group

As a true pioneer in their field, the firm uses a comprehensive and integrated suite of online “pull” strategies to showcase a client’s value proposition and future prospects in an engaging format-- this is in contrast to the traditional sense of the term “IR” where Investor interest is anticipated versus cultivated.

Circadian prides itself on working with select small cap companies in the latter stages of early growth, which are working toward a near-term transformational catalyst to bolster an already distinguished track record of uncovering successful companies before Wall Street and the mainstream media

quote

At our core, Circadian Group is a full service Investor Relations and media creation/distribution firm primarily focused on the healthcare and technology sectors.

History From Our

Case Studies

Case Study #1

PROPANC HEALTH GROUP

(OTCQB: PPCH)

PPCH

Circadian started with Propanc at a very dark time for the Company. At a fraction of a penny, a market cap of less than $1m and investments from quasi-destructive groups this was a very challenging situation for any Investor Relations firm.

After framing the interesting but complex attributes of the Company’s anti-cancer compound within the context of a series of easy to understand articles/ social media/ advertising, the Company’s stock became very active and their market cap increased a staggering 5,000%. During this time the Company was able to secure a well-termed mid-seven-figure financing deal with a large PE fund, usher their main product PRP through pre-clinicals and whole host of positive corporate development.

Program Statistics

Start Date: March 2, 2015       High Price: $0.135
Starting Price: $0.003              % Gain: 4,400%

Case Study #2

ADVANCED MEDICAL ISOTOPE

(OTC: ADMD)

admd

Advanced Medical Isotope, another paradigm-shifting company, is in the radio-brachytherapy device space—in the FDA process to bring a potentially safer and potentially more effective method for treating non-resectable tumors. As an injectable gel radiation that stays in-place after administration Circadian saw the huge potential to humanity if and once approved.

Approaching a potential final De Novo application for marketing clearance with the FDA in the near-future, Circadian is working under contract #2 with the Company to assist with broad global awareness and the reception by Wall street has been well received.

Program Statistics

Start Date: March 1, 2016       High Price: $0.0096
Starting Price: $0.0014              % Gain: 585.71%

Case Study #3

22ND CENTURY GROUP

(NYSE MKT: XXII)

xxii-chart

22nd Century Group is certainly the definition of a paradigm-shifting company ushering huge change in multiple industries. With multiple well-known catalysts for the Company in 2016, Circadian went to work to expose the symbol to as many retail investors as possible, again with the easy-to-understand article strategy. After 6 months’ worth of hard work, the company is delivering on promises with the stock in-tow, now approaching its 52 week high.

XXII recently re-hired Circadian for a second contract which is a testament to a job well done.

Program Statistics

Start Date: April 11, 2016         High Price: $1.39
Starting Price: $0.80                % Gain: 73.75%

Case Study #4

ENDONOVO THERAPEUTICS INC.

(OTCQB: ENDV)

ENDV

Circadian started with Endonovo in December, 2015 at a starting point of a flat-lined stock that had a great story to tell. Fast forward a few months, and the company, through as series of awareness tactics and informational articles, experienced a sizeable gain in both price per share and trading volume.

After mid-way into Circadian’s engagement the company secured significant funding and became significantly more active in corporate development. Endonovo seeks to engage in human trials of their device in short-order.

Program Statistics

Start Date: December 1, 2015        High Price: $0.99
Starting Price: $0.075                     % Gain: 1,220%

Get To Know

Our Team
tyler-headshot

Tyler Troup

Managing Director

Tyler began his career on Bay Street working on the sell-side of one of Canada's largest Broker Dealers: BMO Capital Markets. After his time on Bay Street, Tyler moved into private money management, managing an event driven Investment LP focused on derivatives trading. Tyler then moved into his real passion; Investor Relations, becoming a top Associate with a Canadian headquartered Investor Relations firm, charged with handling the firm's Clean-Tech/ Renewable energy deal-flow. Now as the CEO & Managing Director at Circadian Group, Tyler is focusing his skill-set and high-profile rolodex on the tremendous opportunity within the Canadian Clean-Tech Sector.

Visit me on LinkedIn
ryan-headshot

Ryan Troup

President & COO

As President of Circadian Group, Ryan handles the day-to-day operations as well as the web-based infrastructure. Ryan has 10+ years of experience in the Micro and Small-Cap Natural Resource marketplace. Ryan studied Finance with a concentration in Financial Markets and Investments at Wayne State University and holds his Canadian Securities Course. Ryan’s skill sets include: Market Awareness, Media-Communications, Message Amplification, Communication and Leadership.

Visit me on LinkedIn
member-1

Kaitlyn Thibeault

Chief Administrative Officer

mateo

Mateo Roksandic

Director of Digital Media

sarah

Sarah Ryrie

VP of Video Media

member-1

Burke D'Souza

Vice President

member-1

Stephan Viselli

Vice President

We

Create

Awareness.

Contact Us

Get In touch

Your Name (required)

Your Email (required)

Subject

Your Message

Canada Office

3270 Electricity Drive, Suite 213
Windsor, Ontario
N8W 5J1
Canada
+1 (647)-930-1037
INFO@CIRCADIAN-GROUP.COM

U.S.A.

Office

2033 Main Street, Suite 408
Sarasota, Florida
34237
U.S.A
+1 (305)-929-0440
INFO@CIRCADIAN-GROUP.COM